JP2021531022A5 - - Google Patents

Info

Publication number
JP2021531022A5
JP2021531022A5 JP2021504230A JP2021504230A JP2021531022A5 JP 2021531022 A5 JP2021531022 A5 JP 2021531022A5 JP 2021504230 A JP2021504230 A JP 2021504230A JP 2021504230 A JP2021504230 A JP 2021504230A JP 2021531022 A5 JP2021531022 A5 JP 2021531022A5
Authority
JP
Japan
Prior art keywords
target
cyclic
polyribonucleotide
composition according
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2021504230A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021531022A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/043272 external-priority patent/WO2020023655A1/en
Publication of JP2021531022A publication Critical patent/JP2021531022A/ja
Publication of JP2021531022A5 publication Critical patent/JP2021531022A5/ja
Priority to JP2024159028A priority Critical patent/JP2024169484A/ja
Withdrawn legal-status Critical Current

Links

JP2021504230A 2018-07-24 2019-07-24 環状ポリリボヌクレオチドを含む組成物及びその使用 Withdrawn JP2021531022A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024159028A JP2024169484A (ja) 2018-07-24 2024-09-13 環状ポリリボヌクレオチドを含む組成物及びその使用

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201862702714P 2018-07-24 2018-07-24
US62/702,714 2018-07-24
US201962823569P 2019-03-25 2019-03-25
US62/823,569 2019-03-25
US201962863670P 2019-06-19 2019-06-19
US62/863,670 2019-06-19
PCT/US2019/043272 WO2020023655A1 (en) 2018-07-24 2019-07-24 Compositions comprising circular polyribonucleotides and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024159028A Division JP2024169484A (ja) 2018-07-24 2024-09-13 環状ポリリボヌクレオチドを含む組成物及びその使用

Publications (2)

Publication Number Publication Date
JP2021531022A JP2021531022A (ja) 2021-11-18
JP2021531022A5 true JP2021531022A5 (enExample) 2022-08-02

Family

ID=69182387

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021504230A Withdrawn JP2021531022A (ja) 2018-07-24 2019-07-24 環状ポリリボヌクレオチドを含む組成物及びその使用
JP2024159028A Pending JP2024169484A (ja) 2018-07-24 2024-09-13 環状ポリリボヌクレオチドを含む組成物及びその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024159028A Pending JP2024169484A (ja) 2018-07-24 2024-09-13 環状ポリリボヌクレオチドを含む組成物及びその使用

Country Status (12)

Country Link
US (1) US20210292761A1 (enExample)
EP (1) EP3827084A4 (enExample)
JP (2) JP2021531022A (enExample)
KR (1) KR102950624B1 (enExample)
CN (1) CN112567038A (enExample)
AU (2) AU2019312269A1 (enExample)
BR (1) BR112021001343A2 (enExample)
CA (1) CA3107683A1 (enExample)
IL (1) IL280354A (enExample)
MX (1) MX2021000965A (enExample)
SG (1) SG11202100750XA (enExample)
WO (1) WO2020023655A1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11814627B2 (en) 2016-06-20 2023-11-14 The Board Of The Leland Stanford Junior University Circular RNAs and their use in immunomodulation
CN118416088A (zh) 2017-03-03 2024-08-02 加利福尼亚大学董事会 经由抑制性tRNAs和脱氨酶对突变进行RNA靶向
CA3084824A1 (en) 2017-12-15 2019-06-20 Flagship Pioneering Innovations Vi, Llc Compositions comprising circular polyribonucleotides and uses thereof
EP3946466A2 (en) * 2019-03-25 2022-02-09 Flagship Pioneering Innovations VI, LLC Compositions comprising modified circular polyribonucleotides and uses thereof
EP4022069A4 (en) * 2019-08-28 2023-12-20 The Board of Trustees of the Leland Stanford Junior University MODIFIED CIRCULAR RNAS AND METHOD OF USE THEREOF
AU2020395113A1 (en) 2019-12-02 2022-06-09 Shape Therapeutics Inc. Therapeutic editing
WO2021155175A1 (en) 2020-01-29 2021-08-05 Flagship Pioneering Innovations Vi, Llc Compositions for translation and methods of use thereof
CN111500681A (zh) * 2020-03-20 2020-08-07 青岛大学 用于检测piRNA与mRNA结合的可视化方法及其应用
EP4153152A1 (en) * 2020-05-20 2023-03-29 Flagship Pioneering Innovations VI, LLC Compositions and methods for producing human polyclonal antibodies
KR20230028375A (ko) 2020-06-25 2023-02-28 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 원형 rna 번역을 구동하는 유전 요소와 이를 사용하는 방법
CA3174356A1 (en) * 2020-07-01 2022-01-06 Santosh NARAYAN Compositions and methods for cellular reprogramming using circular rna
CN113249811B (zh) * 2021-05-13 2022-11-08 太原理工大学 一种中空纳米纤维内部固定化生物酶的制备方法
EP4341423A1 (en) 2021-05-18 2024-03-27 Flagship Pioneering Innovations VI, LLC Methods of enriching for circular polyribonucleotides
CN117425735A (zh) 2021-05-18 2024-01-19 旗舰创业创新第六有限责任公司 富集环状多核糖核苷酸的方法
WO2022256578A2 (en) * 2021-06-02 2022-12-08 Beam Therapeutics Inc. Circular guide rnas for crispr/cas editing systems
CA3219570A1 (en) * 2021-06-25 2022-12-29 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for improved protein translation from recombinant circular rnas
CN113264842B (zh) 2021-07-21 2022-03-01 苏州科锐迈德生物医药科技有限公司 一种脂质化合物及包含其的脂质载体、核酸脂质纳米粒组合物和药物制剂
US20250002898A1 (en) 2021-07-27 2025-01-02 Flagship Pioneering Innovations Vi, Llc Devices, systems and methods for processing
CN114591986A (zh) * 2021-07-29 2022-06-07 苏州科锐迈德生物医药科技有限公司 环状rna分子及其在目标蛋白的靶向降解中的应用
DK4271818T3 (da) 2021-09-17 2024-11-04 Flagship Pioneering Innovations Vi Llc Sammensætninger og fremgangsmåder til fremstilling af cirkulære polyribonukleotider
CN116103284B (zh) * 2021-11-09 2025-09-23 中国科学院天津工业生物技术研究所 环形gRNA及其相关生物材料与应用
MX2024007307A (es) 2021-12-17 2024-08-06 Flagship Pioneering Innovations Vi Llc Métodos de enriquecimiento de arn circular en condiciones desnaturalizantes.
KR20250153793A (ko) 2023-01-27 2025-10-27 세일 바이오메디슨스, 인크. 변형된 지질 조성물 및 이의 용도
KR20250092117A (ko) * 2023-12-14 2025-06-23 한국과학기술원 Circular RNA를 이용한 표적 mRNA 발현 저해
WO2026096919A1 (en) 2024-11-01 2026-05-07 Sail Biomedicines, Inc. Novel dipepetide core lipids, lipid carriers, and methods of using thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR604101A0 (en) * 2001-06-29 2001-07-26 Unisearch Limited Aptamers
CN101292033B (zh) * 2005-08-01 2013-04-03 普渡研究基金会 用于活性试剂向细胞的递送的多价rna纳粒
US20110065086A1 (en) 2008-02-21 2011-03-17 Otc Biotechnologies, Llc Methods of producing homogeneous plastic-adherent aptamer-magnetic bead-fluorophore and other sandwich assays
LT3401400T (lt) * 2012-05-25 2019-06-10 The Regents Of The University Of California Būdai ir kompozicijos, skirtos rnr molekulės nukreipiamai tikslinės dnr modifikacijai ir rnr molekulės nukreipiamam transkripcijos moduliavimui
CA3221516A1 (en) 2013-08-22 2015-02-26 E. I. Du Pont De Nemours And Company Plant genome modification using guide rna/cas endonuclease systems and methods of use
US11299739B2 (en) 2016-06-07 2022-04-12 Cepheid Thermostable polymerase inhibitor compositions and methods
EP3986469A1 (en) * 2019-06-19 2022-04-27 Flagship Pioneering Innovations VI, LLC Compositions comprising circular polyribonucleotides for protein modulation and uses thereof

Similar Documents

Publication Publication Date Title
CN109843902B (zh) 用于B型肝炎病毒感染的RNAi剂
US20210292761A1 (en) Compositions comprising circular polyribonucleotides and uses thereof
US20230104113A1 (en) Delivery of compositions comprising circular polyribonucleotides
CN105658797A (zh) 用于调节rna的组合物和方法
JP2009528346A5 (enExample)
JP2012521358A5 (enExample)
KR20200013083A (ko) 짧은 간섭 핵산 (siNA)을 사용한 B형 간염 바이러스 (HBV) 유전자 발현의 RNA 간섭 매개 억제
JP2022536951A (ja) 環状ポリリボヌクレオチドを投与する方法
CN105899663B (zh) 用于基因表达控制的人工模拟miRNA及其用途
JP2014533953A (ja) 治療用rnaスイッチ組成物及び使用方法
CN113249380B (zh) 靶向covid-19新冠病毒的反义寡核苷酸、natac嵌合分子及其应用
CN105073141A (zh) 用于将基因递送到细胞的功能化dna树状聚合物
CN112996913A (zh) 寡聚核酸分子及其应用
CN112941072B (zh) 一种核酸自组装结构及其制备方法和应用
JP5606318B2 (ja) トランスフェクション剤
Suryawanshi et al. A simple alternative to stereotactic injection for brain specific knockdown of miRNA
ES2368298A1 (es) Método para la administración de oligonucleótidos.
WO2025223537A1 (zh) 一种dsRNA、其应用及制备方法
JP2020513849A5 (enExample)
TWI414301B (zh) 以微核醣核酸miR-141為標的治療小核醣核酸病毒感染
WO2025002247A1 (zh) 靶向人血管生成素样蛋白3的核酸及其用途
CN111154755B (zh) 一种双链寡核苷酸dna及其应用
CN102140471B (zh) 一种抑制肿瘤生长的寡聚核酸及其应用
CN116159145A (zh) 含七叶皂苷和/或其盐化合物的转染复合物在促转染的应用
JP7095910B2 (ja) インスリン抵抗性を検出し治療するための組成物および方法